Regeneron Prescription drugs and Sanofi have received FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in persistent obstructive pulmonary illness.
Source link
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
ADVERTISEMENT
- Trending
- Comments
- Latest
